Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
27/04/2026
FORVIA sells its interior business to Apollo's fund for 1.82 billion euros.
Latest
4 m ago
According to the AI Express of each economic news, Southwest Securities released a research report on April 27th, giving a "buy" rating to Wens Foodstuffs Group Co., Ltd. (300498.SZ) with a target price of 20.86 yuan. The main reasons for the rating include: 1) The company's annual revenue remains at the scale of one billion in 2025; 2) The increase in pig industry volume and price reduction, along with cost reduction, ensures profitability; 3) The stability of poultry industry volume and price reduction, along with cost stability, maintains operations. (Daily Economic News)
5 m ago
German Geoscience Research Center: A 5.2 magnitude earthquake occurred in the Afghanistan-Tajikistan border region.
5 m ago
Germany reportedly trying to find a white knight for Deutsche Bank to counter the acquisition of Commerzbank.
7 m ago
Accident resulted in 3 deaths and 1 serious injury, Shaoxing Rail Transit Group fined 1.15 million Yuan.
7 m ago
People over the age of 65 are at high risk. The drug adverse reaction monitoring report will be released in 2025.
See all latest